Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
254.19
+12.73 (5.27%)
At close: Nov 6, 2026, 4:00 PM EST
256.90
+2.71 (1.07%)
After-hours: Nov 6, 2026, 7:59 PM EST

Moderna Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Operating Revenue
1,27394352646973114869381,8201841672,7931,7572931,8284,8593,1204,5315,9257,211
Other Revenue
40513732432822284257-18745134225244218141-
1,3131453896781,0161421089661,8622411672,8111,8313441,8625,0843,3644,7496,0667,211
Revenue Growth (YoY)
29.23%2.11%260.19%-29.81%-45.43%-41.08%-35.33%-65.64%1.69%-29.94%-91.03%-44.71%-45.57%-92.76%-69.30%-29.50%-32.30%9.07%213.16%1162.87%
Cost of Revenue
8957387261,2271,0088199461,8611,6511,3361,1592,3353,4011,8791,9233,1291,9202,0911,5711,600
Gross Profit
418-593-337-5498-677-838-895211-1,095-992476-1,570-1,535-611,9551,4442,6584,4955,611
Selling, General & Admin
282216173308268230212351281268274470442332305375278211268201
Operating Expenses
282216173308268230212351281268274470442332305375278211268201
Operating Income
136-809-510-857-260-907-1,050-1,246-70-1,363-1,2666-2,012-1,867-3661,5801,1662,4474,2275,410
Interest Expense
-18-17-17-8--1-1-6-6-6-6-6-10-13-9-10-8-5-6-5
Interest & Investment Income
6267727073819091103111120103105104109875840157
Currency Exchange Gain (Loss)
----------------952641288
Other Non Operating Income (Expenses)
-2-2--2-494-14322-11-45-495-21-41-29-9
EBT Excluding Unusual Items
178-761-455-797-191-818-957-1,17530-1,256-1,15092-1,921-1,771-2701,6571,2212,4824,2355,411
Gain (Loss) on Sale of Investments
-1--1-24--7-9-9-23-15-22-3722-35-2-4-8-6-1
Legal Settlements
-6-6-878-----------------
Pretax Income
171-767-1,334-799-187-818-964-1,18421-1,279-1,16570-1,958-1,749-3051,6551,2172,4744,2295,410
Income Tax Expense
9159271377-648-10-1471,672-369-384190174277572542
Net Income
162-782-1,343-826-200-825-971-1,12013-1,279-1,175217-3,630-1,380791,4651,0432,1973,6574,868
Net Income to Common
162-782-1,343-826-200-825-971-1,12013-1,279-1,175217-3,630-1,380791,4651,0432,1973,6574,868
Net Income Growth (YoY)
------------85.19%---97.84%-69.91%-68.71%-20.97%199.51%-
Shares Outstanding (Basic)
401398395392390388386385385384382381381381386385390396402405
Shares Outstanding (Diluted)
430398395392390388386385399384382395381381405405412419426431
Shares Change (YoY)
10.26%2.58%2.33%1.82%-2.26%1.04%1.05%-2.53%4.72%0.79%-5.68%-2.47%-7.52%-9.07%-4.93%-6.03%-5.07%-2.78%-0.93%8.65%
EPS (Basic)
0.40-1.96-3.40-2.11-0.51-2.13-2.52-2.910.03-3.33-3.080.57-9.53-3.620.203.812.675.559.1012.02
EPS (Diluted)
0.38-1.96-3.40-2.11-0.51-2.13-2.52-2.910.03-3.33-3.080.54-9.53-3.620.193.642.535.248.5811.29
EPS Growth (YoY)
------------85.11%---97.79%-67.78%-67.14%-18.88%202.11%-

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
-1,606-563-692891-880-922-1,154303-1,717-1,456-1,185402-1,740-1,149-1,3381,5701632172,6313,190
Free Cash Flow Per Share
-3.73-1.42-1.752.27-2.26-2.38-2.990.79-4.30-3.79-3.101.02-4.57-3.02-3.303.880.400.526.187.40
Gross Margin
31.84%--86.63%-80.97%0.79%---92.65%11.33%--16.93%-85.75%--3.28%38.45%42.93%55.97%74.10%77.81%
Operating Margin
10.36%-557.93%-131.11%-126.40%-25.59%-638.73%-972.22%-128.99%-3.76%-565.56%-758.08%0.21%-109.89%-542.73%-19.66%31.08%34.66%51.53%69.68%75.02%
Profit Margin
12.34%-539.31%-345.24%-121.83%-19.68%-580.99%-899.07%-115.94%0.70%-530.71%-703.59%7.72%-198.25%-401.16%4.24%28.82%31.00%46.26%60.29%67.51%
Free Cash Flow Margin
-122.31%-388.28%-177.89%131.42%-86.61%-649.30%-1068.52%31.37%-92.21%-604.15%-709.58%14.30%-95.03%-334.01%-71.86%30.88%4.84%4.57%43.37%44.24%
EBITDA
204-746-451-790-208-850-1,011-1,186-18-1,322-1,230208-1,763-1,775-2881,6601,2792,5234,3065,488
EBITDA Margin
15.54%--115.94%-116.52%-20.47%---122.77%-0.97%--7.40%-96.29%--15.47%32.65%38.02%53.13%70.99%76.11%
D&A For EBITDA
6863596752573960524136202249927880113767978
EBIT
136-809-510-857-260-907-1,050-1,246-70-1,363-1,2666-2,012-1,867-3661,5801,1662,4474,2275,410
EBIT Margin
10.36%--131.11%-126.40%-25.59%---128.98%-3.76%--0.21%-109.89%--19.66%31.08%34.66%51.53%69.68%75.02%
Effective Tax Rate
5.26%-------38.09%------11.48%14.30%11.20%13.53%10.02%
Revenue as Reported
1,3131453896781,0161421089661,8622411672,8111,8313441,8625,0843,3644,7496,0667,211
SEC Filings: 10-K · 10-Q